Moperone

Moperone (Luvatren, since discontinued) is a typical antipsychotic of the butyrophenone class^[2] which is marketed in Japan for the treatment of schizophrenia. It is an antagonist for the D₂ (K_i 0.7–1.9 nM), D₃ (K_i 0.1–1 nM), and 5-HT_2A (K_i 52 nM) receptors. It also has a high binding affinity for the sigma receptors.^[3][4]

Moperone

Clinical data
Trade names	Luvatren (discontinued)
ATC code	N05AD04 (WHO)
Legal status
Legal status	BR: Class C1 (Other controlled substances)[1]
Identifiers
IUPAC name 1-(4-fluorophenyl)-4-[4-hydroxy-4-(4-methylphenyl)piperidin-1-yl]butan-1-one
CAS Number	1050-79-9
PubChem CID	4249
DrugBank	DB13554
ChemSpider	4100
UNII	OU730881W5
KEGG	D02623
CompTox Dashboard (EPA)	DTXSID6049062
ECHA InfoCard	100.012.625
Chemical and physical data
Formula	C22H26FNO2
Molar mass	355.453 g·mol−1
3D model (JSmol)	Interactive image
SMILES CC1=CC=C(C=C1)C1(O)CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1
InChI InChI=1S/C22H26FNO2/c1-17-4-8-19(9-5-17)22(26)12-15-24(16-13-22)14-2-3-21(25)18-6-10-20(23)11-7-18/h4-11,26H,2-3,12-16H2,1H3 Key:AGAHNABIDCTLHW-UHFFFAOYSA-N